Market Place
Sourcing Support
SynOx Appoints U.S.-Based CMO & CCO to Strengthen Executive Team
07 Nov 2024 //
GLOBENEWSWIRE
SynOx Therapeutics Raises $92M in Series B, Doses First Patients
30 Oct 2024 //
GLOBENEWSWIRE
SynOx Secures $35M Debt For Emactuzumab Commercialization
30 Apr 2024 //
PR NEWSWIRE
SynOx Therapeutics Secures up to $35m Debt Financing
30 Apr 2024 //
PHARMACEUTICAL MANUFACTURING
SynOx Raises $75M Series B For TGCT Phase 3
22 Apr 2024 //
PR NEWSWIRE
Emactuzumab designated as an Orphan Medicinal Product in Europe
31 Aug 2022 //
PRNEWSWIRE
SnyOx taps chief medical, tech officers week after CEO hire
03 Aug 2021 //
FIERCEBIOTECH
Ex-Kiadis CBO takes the helm at SynOx after $358M Sanofi buyout
27 Jul 2021 //
FIERCEBIOTECH
Ex-Kiadis CBO takes the helm at SynOx after $358M Sanofi buyout
27 Jul 2021 //
FIERCEBIOTECH
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.